Horizon Biologicals (India) Private Limited
About Horizon Biologicals (India) Private Limited
Data last updated:
Horizon Biologicals (India) Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 August 2002.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24231MH2002PTC136786. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It was led by directors including Manohar Mulchand Patidar and Padma Manohar Patidar.
Its last annual general meeting (AGM) was held on 21 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at 36/37 Shreenath Bhawan 3rd Flpicket Road Opp G T Hospital, Mumbai, Maharashtra, India – 400002.
As per the financials filed for FY 2019, the company reported a revenue of ₹11,000, a decline of 15% compared to the previous year. For the same year it recorded a net loss of ₹869 (net margin -7.9%) and EBITDA of ₹11,000 (EBITDA margin 100%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years.
Company details
Contact details
Horizon Biologicals (India) Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address36/37 Shreenath Bhawan 3rd Flpicket Road Opp G T Hospital, Mumbai, Maharashtra, India – 400002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Horizon Biologicals (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Horizon Biologicals (India) Private Limited
FY 2019 filings availableHorizon Biologicals (India) Private Limited reported revenue of ₹11,000 (down 15% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 17% over three years, including a 15% fall in the latest year. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹11,000 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹869 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 100% | ||||
| Net Profit Margin | -7.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Horizon Biologicals (India) Private Limited, buy the company report.
Board of directors of Horizon Biologicals (India) Private Limited
Horizon Biologicals (India) has 6 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manohar Mulchand Patidar | Director | 09 Aug 2002 | 24 Years 3 Months | As last reported |
| Padma Manohar Patidar | Director | 09 Aug 2002 | 24 Years 3 Months | As last reported |
| Narendra Ganpatlal Dave Also directs: Narendra Dave & Co LLP | Director | 09 Aug 2002 | 24 Years 3 Months | As last reported |
| Purti Balrajkishore Misra Also directs: Mohammdi Healthcare LLP, Pirincs Pharmaceuticals Private Limited, Elephanta Construction Co. Private Limited and 4 more | Director | 09 Aug 2002 | 24 Years 3 Months | As last reported |
| Balraj Kishore Mata Prasad Misra Also directs: Mohammdi Healthcare LLP, Pirincs Pharmaceuticals Private Limited, Elephanta Construction Co. Private Limited and 4 more | Director | 09 Aug 2002 | 24 Years 3 Months | As last reported |
| Renu Narendra Dave | Director | 09 Aug 2002 | 24 Years 3 Months | As last reported |
Peer comparison
Horizon Biologicals (India) Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tini Pharma Private Limited | ₹11,849 (FY 2019) | -87.0% | Hyderabad, Andhra Pradesh, India | |||
| Sovitas Healthcare Private Limited | ₹11,586 (FY 2025) | -90.0% | Mumbai, Maharashtra, India | |||
| Ethigen Labs Private Limited | ₹11,133 (FY 2016) | Telangana, India | ||||
| Khatushyam Medical Services Private Limited | ₹11,030 (FY 2025) | 4.0% | Delhi, India | |||
| Horizon Biologicals (India) Private Limitedthis company | ₹11,000 (FY 2019) | -₹869 | -7.9% | -15.0% | Mumbai, Maharashtra, India | |
| Coley Pharma Private Limited | ₹11,000 (FY 2025) | Turkapally, Telangana, India | ||||
| Duphar Bioscience Private Limited | ₹10,600 (FY 2025) | Ahmedabad, Gujarat, India | ||||
| Elitus Healthcare Private Limited | ₹10,122 (FY 2024) | -96.0% | Mumbai, Maharashtra, India | |||
| Vario Pharma Private Limited | ₹10,100 (FY 2021) | Thane, Maharashtra, India | ||||
| Araneae Pharmaceutical Private Limited | ₹10,001 (FY 2025) | Allahabad, Uttar Pradesh, India | ||||
| Zudik Organics Private Limited | ₹10,000 (FY 2025) | Delhi, India |
To see the full peer comparison of Horizon Biologicals (India) Private Limited, buy the company report.
Auditor
Horizon Biologicals (India) Private Limited is audited by P D KHIVANSARA & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P D KHIVANSARA & CO | FY 2019 | 105151W |
Shareholding
The shareholding of Horizon Biologicals (India) Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Horizon Biologicals (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Horizon Biologicals (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Horizon Biologicals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Horizon Biologicals (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Horizon Biologicals (India) Private Limited, buy the company report.
Recent activity
Horizon Biologicals (India) Private Limited has 6 board changes on record since 2002: 6 appointments. The latest: Balraj Kishore Mata Prasad Misra was appointed as Director on 09 Aug 2002.
Frequently asked questions
Horizon Biologicals (India) has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Horizon Biologicals (India) was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 09 August 2002 and is registered under CIN U24231MH2002PTC136786. The company has been struck off by the Registrar of Companies and is no longer operational.
Horizon Biologicals (India) had 6 directors:
- Manohar Mulchand Patidar - Director
- Padma Manohar Patidar - Director
- Narendra Ganpatlal Dave - Director
- Purti Balrajkishore Misra - Director
- Balraj Kishore Mata Prasad Misra - Director
- Renu Narendra Dave - Director
The CIN (Corporate Identification Number) of Horizon Biologicals (India) is U24231MH2002PTC136786. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Horizon Biologicals (India) is at 3637 Shreenath Bhawan 3rd Flpicket Road Opp G T Hospital, Mumbai, Maharashtra, India – 400002.
Horizon Biologicals (India) was incorporated on 09 August 2002. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Horizon Biologicals (India) on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 21 September 2019. Year-wise statements from 2015 are in the company report.
No. Horizon Biologicals (India) has 1 GST registration on record and it is cancelled or inactive.
Horizon Biologicals (India) operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
The peers of Horizon Biologicals (India) by revenue are Tini Pharma Private Limited, Sovitas Healthcare Private Limited, Ethigen Labs Private Limited, Khatushyam Medical Services Private Limited, Coley Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Balraj Kishore Mata Prasad Misra was appointed as Director on 09 Aug 2002. Manohar Mulchand Patidar was appointed as Director on 09 Aug 2002. Narendra Ganpatlal Dave was appointed as Director on 09 Aug 2002. Horizon Biologicals (India) has 6 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
